Senior Director Biopharma Services - LC-MS/MS
KCAS
Olathe, Kansas
Dawn R. Dufield (PhD) is the Senior Director of Biopharmaceuticals (LC-MS/MS) Services at KCAS. She has been at KCAS since 2018. Previously she had been with Pfizer and legacy companies for over 20 years working in the quantitative LC-MS/MS field. She has extensive experience in developing qualitative and quantitative LC-MS/MS assays for both large and small molecules. She was one of the early pioneers of using immunoaffinity combined with LC-MS/MS to offer additional selectivity which is now commonly referred to as Hybrid LCMS and is a co-author on a white paper on recommendations for validation of LCMS based bioanalytical methods for protein biotherapeutics. She has experience with many Biopharma modalities such as peptides, proteins, fusion proteins, ADC’s, Mabs etc., as well as numerous biomarker panels such as glycosphingolipids, amino acids and eicosanoids. She is a large proponent of using the correct technology to best answer the question. She has numerous publications in her field and is an active member of the AAPS and ASMS.
Disclosure information not submitted.